Brown-Forman reported QQ1 2026 revenue of USD 924.0 million, down 2.84% year over year but up 3.36% quarter over quarter, reflecting a modest top-line pullback versus the prior-year period with some quarterly seasonality. Gross margin stood at 59.74% and operating margin at 28.14%, underscoring the durability of pricing power and a highly cash-generative business model in the premium beverages segment. Net income reached USD 170.0 million, translating to a net margin of 18.40% and earnings per share (EPS) of USD 0.36, with YoY declines primarily a function of base effects and mix rather than deteriorating core profitability.
The company generated USD 160.0 million in cash from operations and USD 129.0 million of free cash flow in the quarter, enabling USD 107.0 million in dividends paid and contributing to a net debt position of roughly USD 2.23 billion. Brown-Forman maintains a strong liquidity profile (cash and cash equivalents of USD 471.0 million, current ratio 2.79) and a disciplined capital structure (total debt USD 2.701 billion; debt-to-capitalization about 40.4%). The dividend payout remains sizable at 62.9% of earnings, supported by solid cash generation and ongoing brand strength in a premium, consumer-defensive category.
Looking ahead, management commentary (where available in the provided data) and the QoQ acceleration in profitability suggest continued operating leverage and mix benefits from core portfolios. The absence of explicit full-year guidance in the input data means readers should anchor expectations to medium-term fundamentals: stable gross margins, disciplined SG&A, and continued free cash flow generation that sustains the dividend and supports selective deleveraging or strategic investments as conditions allow.
Liquidity and Cash Flow
- Net Cash Provided by Operating Activities: USD 160.0m; Free Cash Flow: USD 129.0m
- Cash at End of Period: USD 490.0m; Cash & Equivalents: USD 471.0m
- Dividends Paid: USD 107.0m; Net Cash Used Provided by Financing Activities: USD -138.0m
- Net Change in Cash: USD 27.0m; CFO per Share: USD 0.34; FCF per Share: USD 0.273
Balance Sheet Health
- Total Assets: USD 8.171b; Total Liabilities: USD 4.183b; Total Equity: USD 3.988b
- Total Debt: USD 2.701b; Net Debt: USD 2.230b
- Working Capital Strength: Current Ratio 2.79; Quick Ratio 1.06; Cash Ratio 0.32
- Leverage: Debt to Total Capitalization 40.4%; Debt to Equity 0.677; Interest Coverage ~10.4x
Invested Capital and Valuation
- Payout Ratio: 62.9%; Dividend Yield: ~0.79%; Price-to-Book ~3.42x; P/E ~20.1x; EV/EBITDA ~59.4x
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
924.00M
-2.84%
3.36%
Gross Profit
552.00M
-2.30%
7.60%
Operating Income
260.00M
-7.47%
26.83%
Net Income
170.00M
-12.82%
16.44%
EPS
0.36
-12.20%
16.54%
Key Financial Ratios
Gross Profit Margin
Good
59.70%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Excellent
28.10%
Operating margin is exceptional, indicating strong pricing power and operational efficiency
Net Profit Margin
Good
18.40%
Net profit margin is healthy and competitive within industry standards
Return on Assets
Weak
2.08%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
4.26%
Return on equity suggests inefficient capital allocation
Current Ratio
Strong
2.79
Current ratio indicates excellent liquidity and financial flexibility